Lifeward (LFWD) Notes Payables (2025)
Lifeward (LFWD) reported Notes Payables of $2.8 million for Q4 2025.
Lifeward (LFWD) Notes Payables (2025) Analysis & Trends
Lifeward (LFWD) has 1 years of Notes Payables data on file, last reported at $2.8 million in Q4 2025.
- For the quarter ending Q4 2025, Notes Payables changed N/A year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2025 stood at $2.8 million (changed N/A YoY), and the FY2025 full-year result was $2.8 million, changed N/A from the prior year.
- Notes Payables was little changed at $2.8 million in Q4 2025.
- In the past five years, Notes Payables ranged from a high of $2.8 million in Q4 2025 to a low of $2.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.80 Mn |